These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 11736861)

  • 21. Salmeterol and fluticasone propionate given as a combination. Lack of systemic pharmacodynamic and pharmacokinetic interactions.
    Kirby S; Falcoz C; Daniel MJ; Milleri S; Squassante L; Ziviani L; Ventresca GP
    Eur J Clin Pharmacol; 2001; 56(11):781-91. PubMed ID: 11294367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of fluticasone propionate inhaled via the Diskhaler and Diskus powder devices in healthy volunteers.
    Mackie AE; McDowall JE; Falcoz C; Ventresca P; Bye A; Daley-Yates PT
    Clin Pharmacokinet; 2000; 39 Suppl 1():23-30. PubMed ID: 11140430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative clinical pharmacology of mometasone furoate, fluticasone propionate and fluticasone furoate.
    Daley-Yates PT; Deans A; Mehta R; Sousa AR
    Pulm Pharmacol Ther; 2022 Dec; 77():102171. PubMed ID: 36243386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patients.
    Clark DJ; Lipworth BJ
    Thorax; 1997 Jan; 52(1):55-8. PubMed ID: 9039246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of inhaled ciclesonide and fluticasone propionate on cortisol secretion and airway responsiveness to adenosine 5'monophosphate in asthmatic patients.
    Derom E; Van De Velde V; Marissens S; Engelstätter R; Vincken W; Pauwels R
    Pulm Pharmacol Ther; 2005; 18(5):328-36. PubMed ID: 15939311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.
    Galant SP; van Bavel J; Finn A; Gross G; Pleskow W; Brown A; Hamedani AG; Harding SM
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):273-80. PubMed ID: 10094218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo comparison of the relative systemic bioavailability of fluticasone propionate from three anti-static spacers and a metered dose inhaler.
    Nair A; Menzies D; Hopkinson P; McFarlane L; Lipworth BJ
    Br J Clin Pharmacol; 2009 Feb; 67(2):191-8. PubMed ID: 19220273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical efficacy and safety of fluticasone propionate 250 microg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with mild to moderate asthma. French study group.
    Tonnel AB; Bons J; Legendre M; Prud'Homme A; Bugnas B; Evano-Celli I; Stuart AM
    Respir Med; 2000 Jun; 94 Suppl B():S29-34. PubMed ID: 10919683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical efficacy and safety of fluticasone propionate 1 mg per day administered via a HFA 134a pressurized metered dose inhaler to patients with moderate to severe asthma. International study group.
    Perruchoud AP; Lundback B; Yigla M; Sykes AP
    Respir Med; 2000 Jun; 94 Suppl B():S35-41. PubMed ID: 10919684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of a spacer on total systemic and lung bioavailability in healthy volunteers and in vitro performance of the Symbicort
    Gillen M; Forte P; Svensson JO; Lamarca R; Burke J; Rask K; Larsdotter Nilsson U; Eckerwall G
    Pulm Pharmacol Ther; 2018 Oct; 52():7-17. PubMed ID: 30077809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fine particle mass from the Diskus inhaler and Turbuhaler inhaler in children with asthma.
    Bisgaard H; Klug B; Sumby BS; Burnell PK
    Eur Respir J; 1998 May; 11(5):1111-5. PubMed ID: 9648964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Salmeterol and fluticasone propionate (50/250 microg) administered via combination Diskus inhaler: as effective as when given via separate Diskus inhalers.
    Chapman KR; Ringdal N; Backer V; Palmqvist M; Saarelainen S; Briggs M
    Can Respir J; 1999; 6(1):45-51. PubMed ID: 10202220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of budesonide Turbuhaler compared with that of beclomethasone dipropionate pMDI in Japanese patients with moderately persistent asthma.
    Miyamoto T; Takahashi T; Nakajima S; Makino S; Yamakido M; Mano K; Nakashima M; Tollemar U; Selroos O;
    Respirology; 2001 Mar; 6(1):27-35. PubMed ID: 11264760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic effects of inhaled fluticasone propionate and budesonide in adult patients with asthma.
    Derom E; Van Schoor J; Verhaeghe W; Vincken W; Pauwels R
    Am J Respir Crit Care Med; 1999 Jul; 160(1):157-61. PubMed ID: 10390394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the buccal component of systemic absorption with inhaled fluticasone propionate.
    Dempsey OJ; Coutie WJ; Wilson AM; Williams P; Lipworth BJ
    Thorax; 1999 Jul; 54(7):614-7. PubMed ID: 10377207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial.
    Noonan M; Rosenwasser LJ; Martin P; O'Brien CD; O'Dowd L
    Drugs; 2006; 66(17):2235-54. PubMed ID: 17137405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical efficacy and safety of budesonide Turbuhaler in adults.
    Hultquist C
    J Aerosol Med; 1994; 7(Suppl 1):S63-6. PubMed ID: 10147082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early bronchodilatory effects of budesonide/formoterol pMDI compared with fluticasone/salmeterol DPI and albuterol pMDI: 2 randomized controlled trials in adults with persistent asthma previously treated with inhaled corticosteroids.
    Hampel FC; Martin P; Mezzanotte WS
    J Asthma; 2008 May; 45(4):265-72. PubMed ID: 18446589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical pharmacokinetics of inhaled budesonide.
    Donnelly R; Seale JP
    Clin Pharmacokinet; 2001; 40(6):427-40. PubMed ID: 11475468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic exposure and urinary cortisol effects of fluticasone propionate formulated with hydrofluoroalkane in 4- to 11-year-olds with asthma.
    Kim KT; Milgrom H; Yoon YK; Levy AL; Matz P; Welch MJ; Cahn A; Collins DA; Kathman S; Mehta R; Su SF; Kunka RL
    J Clin Pharmacol; 2008 Jan; 48(1):108-16. PubMed ID: 18094223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.